https://www.selleckchem.com/pr....oducts/monastrol.htm
05), nor in the tPSA level or the results of DRE and MRI at 12, 24, 36, 48 and over 48 months (P 0.05). CONCLUSIONS SABT is safe for PCa patients undergoing radical prostatectomy and does not increase the tumor recurrence rate after surgery.Objective To explore the efficacy and toxicity of stereotactic body radiation therapy (SBRT) versus conventional intensity-modulated radiation therapy (IMRT) in the treatment of prostate cancer. METHODS Forty patients with localized prostate adenocarcinoma received SBRT for 5 doses totaling 36
Beğen
Yorum Yap
Paylaş
